Literature DB >> 3141101

Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures.

E Salminen1, I Elomaa, J Minkkinen, H Vapaatalo, S Salminen.   

Abstract

Twenty-four female patients suffering from gynaecological malignancies and scheduled for internal and external irradiation of the pelvic area (pelvic dose 5000 cGy) were selected for a study on prevention of intestinal side-effects by live Lactobacillus acidophilus cultures. The patients were randomised into two groups. Both groups received dietary counselling recommending a low-fat and low-residue diet during radiotherapy. The control group received dietary counselling only. The test group received 150 ml of a fermented milk test product supplying them with at least 2 X 10(9) live Lactobacillus acidophilus bacteria daily and 6.5% lactulose as substrate for the bacteria. The results indicated that the test product appeared to prevent radiotherapy-associated diarrhoea. However, flatulence was increased probably due to lactulose ingestion in the test group.

Entities:  

Mesh:

Year:  1988        PMID: 3141101     DOI: 10.1016/s0009-9260(88)80296-4

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  29 in total

Review 1.  Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action.

Authors:  Matthew A Ciorba; Christopher L Hallemeier; William F Stenson; Parag J Parikh
Journal:  Curr Opin Support Palliat Care       Date:  2015-06       Impact factor: 2.302

2.  Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer.

Authors:  Hadeel Hassan; M Rompola; A W Glaser; S E Kinsey; R S Phillips
Journal:  Support Care Cancer       Date:  2018-04-27       Impact factor: 3.603

Review 3.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

Review 4.  The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis.

Authors:  Y-H Wang; N Yao; K-K Wei; L Jiang; S Hanif; Z-X Wang; C-X Pei
Journal:  Eur J Clin Nutr       Date:  2016-06-22       Impact factor: 4.016

Review 5.  New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.

Authors:  Rachna Patel; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

Review 6.  Radiation-induced small bowel disease: latest developments and clinical guidance.

Authors:  Rhodri Stacey; John T Green
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

Review 7.  Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.

Authors:  S Salminen; E Isolauri; E Salminen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-10       Impact factor: 2.271

8.  Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.

Authors:  Imjai Chitapanarux; Taned Chitapanarux; Patrinee Traisathit; Sudkaneung Kudumpee; Ekkasit Tharavichitkul; Vicharn Lorvidhaya
Journal:  Radiat Oncol       Date:  2010-05-05       Impact factor: 3.481

Review 9.  Probiotic therapy in radiation-induced intestinal injury and repair.

Authors:  Matthew A Ciorba; William F Stenson
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

10.  Long-term prognosis in patients with severe late radiation enteropathy: a prospective cohort study.

Authors:  Annette Larsen; Jon B Reitan; Steinar T Aase; Martin Hauer-Jensen
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.